Email This Article

Headlines & Perspectives
Analysts: Celgene Arthritis Drug Could Sell Well
By The Associated Press
06/16/09 - 12:24 PM EDT
Analysts see Celgene's apremilast as potential competitor in lucrative arthritis market
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,501.05 1,114.11 2,212.10 35.46
Oil *
71.84
UP
29.55
UP
7.70
UP
21.79
UP
0.06
10 Yr
3.55%
SPDR Gold
110.24
+0.28%
+0.70%
+0.99%
+0.17%
Data delayed 20 minutes

Brokerage Partners